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Accepted 21 October 1997Endometriosis: Analysis of 1417 Consecutive Cycles of IVF.
Spandorfer SD, C Fierro, Kligman, H-C Liu, A Neuer, SS Witkin,
Z Rosenwaks. The Center for Reproductive Medicine and Infertil-
ity, Department of Obstetrics and Gynecology, The New York Hos-
pital--Cornell Medical Center, New York, NY.
Objective: Endometriosis is a very common cause of infertility and
often an indication for in vitro fertilization with embryo trans-
fer (IVF-ET). When patients have severe endometriosis affecting
the tubes, infertility is understandable. However, the mechanism
of infertility with minimal or mild disease is unclear. Some au-
thors have purported a decline in fecundity after IVF-ET in endo-
metriosis patients in advanced stages of disease. It has also been
suggested that treatment of minimal or mild endometriosis in in-
fertility patients who are attempting natural conception is benefi-
cial. The purpose of this study was to evaluate the effect of the
presence of endometriosis and the stage of disease on IVF-ET
outcome.
Methods: 1417 consecutive cycles in 872 patients undergoing IVF-
ET at The New York Hospital--Cornell Medical Center from
1989 to 1997 were analyzed in a retrospective study. Patients were
identified by the presence of endometriosis as a diagnosis (pri-
mary, secondary or the presence of endometriosis) in a computer
database. All charts were reviewed for the stage of endometrio-
sis and classified according to ASRM. Patients were treated with
standard ovulation induction protocols and underwent IVF-ET
according to previously published guidelines. Demographics,
stimulation protocols and results, retrieval and transfer data, and
pregnancy outcomes were analyzed. Clinical pregnancy was de-
fined as the presence of a gestational sac. An ongoing pregnancy
was defined as a pregnancy continuing beyond the 20th week of
gestation. Analysis of variance, Chi square, and student’s t-test
were utilized when appropriate. P < 0.05 was considered signifi-
cant.
Results: 1196 (84.4%) of the 1417 initiated cycles went to re-
trieval. 1105/1196 (92.3%) underwent an embryo transfer. An
overall clinical pregnancy rate/transfer of 44.7% (495/1105) and
an overall ongoing pregnancy rate/transfer of 37.1% were noted.
In analyzing all cycles that went to transfer, the stage of disease
had no significant effect on peak estradiol levels, number of ma-
ture oocytes or embryos transferred, or pregnancy outcome. As
expected, age was found to have a significant effect on IVF-ET
outcome. Patients under 40 years old had a significantly higher
clinical pregnancy rate/transfer than those 40 and over (48.4% vs.
31.8%; p < 0.001). To remove the effect of individual patients
with multiple failed cycles and perhaps other unknown contribut-
ing causes of infertility, we next analyzed the first cycle of each
patient with endometriosis. Once again, the stage of disease had
no significant effect on peak estradiol levels, number of mature
oocytes or embryos transferred, or pregnancy outcome. In analyz-
ing the population by stimulation protocol, patients with lupreolide
acetate down-regulated cycles were found to be younger, stim-
ulate better, and had significantly higher clinical pregnancy rates
(48.9% vs. 27.2%; P < 0.001). Given that patients with lupreolide
acetate down-regulated cycles were found to have better outcomes,
we than analyzed these patients to detect if stage of disease had any
effect on IVF-ET outcome. In these patients, lower stages of en-
dometriosis were associated with older women that stimulated bet-
ter, had more oocytes retrieved, and had more embryos fertilized.
Despite this, no differences in the ultimate number of embryos
transferred or, more importantly, pregnancy outcomes were de-
tected. We then analyzed the 741 cycles of patients with pure
endometriosis as the only cause of infertility. In these patients, the
stage of disease had no significant effect on peak estradiol levels,
number of mature oocytes, number of embryos transferred, or preg-
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nancy outcome. We then attempted to analyze for the presence of
endometriosis and its affect on outcome after IVF-ET. Given that
most of the variability in pregnancy outcomes after IVF-ET is
related to age and that until the age of 35 we have implantation rates
that are constant, we then analyzed all ICSI cycles (1995-1996) in
patients with maternal age 35 years or less and male-only infertility
(n 460) and compared this to women 35 years or less with male
and endometriosis infertility (n 43, same time period) in an
attempt to assess the effect of the presence of endometriosis on
outcome. In this separate analysis, the presence of endometriosis
did not effect the stimulation, retrieval or transfer parameters. Clini-
cal and ongoing pregnancy rates/transfer were similar (male vs.
male and endometriosis 63.5% vs. 56% and 56.7% vs. 46.5%,
respectively; P>0.05).
Conclusion: We have demonstrated in this large study that the
stage of endometriosis may have a slight effect on stimulation
(lower stage disease in good prognosis patients had better re-
sponses), but, more importantly, no differences in pregnancy out-
comes were detected. Furthermore, the mere presence of endome-
triosis as a factor of infertility did not appear to affect IVF-ET
outcomes.
1. Fertil Steril 65:603
2. N Engl J Med 337:217
3. Fertil Steril 67:817, 1997.
Decidualization Related Expression of Plasminogen Activators
in Human Endometrial Stromal Cells. Papp CS, Toth-Pal E,
Schatz F, Lockwood C, Papp Z. st Dept. of Ob/Gyn, Semmelweis
Medical School, Budapest, Hungary (C.S.P., E.T.-P. Z.P.); Dept. of
Ob/Gyn, New York University Medical Center, New York (F.S., C.
L.).
To determine whether altered expression of the tissue type (tPA)
and urokinase type (uPA) plasminogen activators accompanies de-
cidualization, confluent monolayers of endometrial stromal cells
from predecidualized human endometria were incubated for 3 days
in a defined medium containing 10-SM E2, 10-TM medroxyproges-
terone-acetate (MPA), E2+MPA, or 0.1% ethanol as control. It was
detected by specific ELISAs that added MPA reduced uPA levels
by 19% and tPA by 33%. Even greater reductions were seen in
response to E2+MPA (74% for uPA and 49% for tPA). A chromo-
genic assay was used to discriminate between the amounts of fibrin-
independent PA activity (uPA) and fibrin-dependent activity (tPA)
in the stromal cell conditioned medium. Two hours preincubation at
37C increased measured uPA activity under control conditions by
about 20-fold, indicating that the stromal cells released uPA pre-
dominantly as catalytically inactive pro-uPA. Both uPA and tPA
activity were refractory to E2, inhibited by MPA, and synergisti-
cally inhibited by E2+MPA. Interestingly enough, E2+MPA re-
duced the activities of secreted uPA and tPA to nondetectable levels
despite significant immunogenic levels of both PAs. This prefer-
ential inhibition of activity versus antigen may reflect the action of
the potent PA inhibitor, PAI-1, whose output by the cultured stro-
mal cells is elevated by MPA and even more increased by
E2+MPA. During implantation, inhibition of decidual cell ex-
pressed tPA, the prime fibrinolytic agent, by the predominant ste-
roids of pregnancy can prevent hemorrhage, whereas reduction in
decidual cell derived pro-uPA can lower the paracrine supply to
specific trophoblast cell uPA receptors and thereby limit tropho-
blast invasiveness.
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Monoclonal Antibody Against Phosphatidylserine Interferes
with the Differentiation of Choriocarcinoma Models of Tropho-
blast. Rote NS, Vogt E, Devere G, And Ng AK. Departments of
Microbiology and Immunology and Obstetrics and Gynecology,
Wright State University School of Medicine, Dayton, OH, USA.
Many studies have confirmed that both monoclonal and naturally
occurring antiphospholipid antibodies (aPLs) react with trophoblast
from st and 2nd trimester human placenta. Using choriocarcinoma
models (BeWo and JAR) that mimic trophoblast differentiation, we
investigated the effects of monoclonal aPLs on trophoblast. Differ-
entiating choriocarcinomas externalize phosphatidylserine (PS) that
is measurable by the increased binding to the cell surface of an-
nexin V and monoclonal aPLs against PS (aPS). They concurrently
externalize endogenous annexin V, which binds to the PS and pre-
vents formation of the prothrombinase complex. Choriocarcinomas
also undergo invasion of matrigel-coated filters and intercellular
fusion leading to syncytium formation. We have previously shown
that aPLs prevent intercellular fusion. We tested the effects of
monoclonal aPLs on the invasion of JAR. 2.5 104 JAR cells/0.5
ml was applied to matrigel-coated filters. In some chambers the
media was supplemented with monoclonal aPS or control class-
matched monoclonals against cardiolipin and bacterial peptidogly-
can. Chambers were incubated at 37C for 24 hours and the filters
stained and examined microscopically for cells on the underside.
Results were compared to media alone (average: 50 cells/underside
of membrane). Negative control monoclonals slightly, but not sig-
nificantly, affected migration, aPS significantly (P<0.001) de-
creased migration ofJAR across the membrane. We concluded that
PS is expressed on the trophoblast surface during invasion of ex-
tracellular matrix, and aPS inhibits the process. Using immunoper-
oxidase, we also investigated the effects of aPS on annexin V
expression on BeWo. Undifferentiated BeWo expressed cytoplas-
mic, but not surface, annexin V and did not bind exogenous annexin
V. After differentiation, BeWo expressed surface annexin V and
bound additional exogenous annexin V. When differentiation oc-
curred in the presence of aPS, there was little detectable endog-
enous or exogenous annexin V surface binding. Using FITC-
conjugated annexin V, aPS removed previously bound annexin V
from the trophoblast surface. Control monoclonals against cardio-
lipin and bacterial peptidoglycan had no effect on annexin V ex-
pression. Prothrombin did not bind to undifferentiated cells and
only bound slightly to differentiated cells. Preincubation with 3SB
increased prothrombin binding. We concluded that PS and annexin
V are externalized during trophoblast differentiation, and aPS can
remove annexin V, opening prothrombin binding sites. Our data
suggest that aPLs against PS can directly affect trophoblast function
by limiting the depth of decidual invasion and concurrently creating
a procoagulant surface on trophoblast exposed to the maternal cir-
culation.
Production of Signal Transducers Differs Between Cultured
Cervical and Myometrial Cells Incubated With Prostaglandin
E2. Lejeune V, Dallot E, Ferr F, Cabrol D. INSERM U361, Pa-
vilion Baudelocque, Maternit6 Port Royal-Cochin, Universit6 Ren6
Descartes, Paris, France.
Prostaglandin E2 (PGE2) plays a key role in parturition, and ad-
ministration of a PGE2 agonist at any point of pregnancy can in-
duce delivery. PGE2 receptors are pharmacologically divided into
at least four subtypes, EP1, EP2, EP3 and EP4, on the basis of the
responses to various agonists and antagonists, and all types have
been described to be coupled with G proteins. These subtypes differ
in signal transduction, and they are presumed to be coupled with
Ca mobilization (some via inositol triphosphate [IP3] synthesis)
and stimulation or inhibition of adenyl cyclase. Therefore, the phar-
macological effects of PGE2 are quite diverse. PGE2 can induce
muscular contraction via IP3 production and Ca++ mobilization, or
it can induce muscular relaxation and cervical maturation via cyclic
AMP (cAMP) production. In this study, we examined the produc-
tion ofcAMP and inositol phosphates (IPs) by cultured myometrial
and cervical cells, incubated with increasing concentrations of
PGE2. Myometrial and cervical cells maintained in culture from
uterine biopsies have already been described by our laboratory to
maintain a high degree of differentiation, only if cultured within the
last 3 days in a serum free-medium. There is a dose-dependent
increase in cAMP production by cervical cells, much higher than by
myometrial cells. In contrast, PGE2 induces a dose-dependent in-
crease in IP production by myometrial cells, much higher than in
cervical cells. When myometrial cells are maintained in the pres-
ence of serum, they lose their muscular phenotype, and their re-
sponse patterns become like those of cervical cells. These results
suggest that PGE2 utilizes different signal transduction pathways in
myometrial and cervical cells, which have been cultured in good
differentiation conditions. Therefore, the actions of PGE2 lead to
active muscular contraction in myometrial cells and relaxation in
cervical cells, and both of these contradicting actions are necessary
for parturition.
Free Fatty Acids and Alpha-Fetoprotein Profiles in the Hu-
man Maternal-Fetal-Placenta Unit at Term Pregnancy.
Benassayag C, Rigoud V, Civel C, Mignot TM, Haourigul M, Has-
sid J, Leroy MJ, Nunez EA, Ferre F. INSERM U361, Maternit6
Baudelocque, Universite Ren6 Descartes, 75014 Paris, France
(C.B., V.R., C.C., T.M.M., M. H., M.J.L., F.F.); Laboratoire de
biochimie endocrienne, Facilt6 de Mddecine Xavier Bichat, Uni-
versit6 Denis Diderot, 75870 Paris, France (J.H., E.A.N.).
Free fatty acids (FFA), especially polyunsaturated fatty acids
(PUFA), play a major role in multifactorial processes involved in
normal gestation, fetal development, and parturition. PUFA are cell
signaling molecules which are involved in the mediation of immu-
nological, metabolic, and endocrine signals within the materno-
feto-placental unit. They act as immunomodulators in the local
regulation of maternal cell-mediated immunity, and as growth fac-
tors influencing the proliferation of smooth muscle cells. PUFA are
precursors of eicosanoids. They also modulate the activity of key
enzymes of steroid metabolism and the way in which these hor-
mones act in the myometrium. Consequently, PUFA are directly or
indirectly involved in the control of myometrial activity at the time
of parturition. PUFA, like arachidonic (C20:4w-6) and docosahex-
aenoic acids (C22:6w-3), bind with high affinity to the alpha-
fetoprotein (AFP) in fetal circulation. AFP, as PUFA, is also among
the substances claimed to influence cell growth, to participate in
inflammatory reactions, and to act as regulators of the immune
response. The distribution of FFA and AFP were studied in each
compartment of the maternal-fetal unit on women (n 28) who
underwent elective cesarean section at term before the onset of
labor. The study focused on the fetal-maternal interface, the ma-
ternal intervillous blood (I), space delineated both by the fetal syn-
cytiotrophoblast and by maternal decidua. The peripheral maternal
(M) and fetal circulations (umbilical arteries [A] and vein IV]) were
comparatively analyzed. The results indicate a differential distribu-
tion of FFA and AFP. The plasma FFA levels were similar in
(725+621xM) andM (760+70txM), but those ofA (250+30xM) and
V (225+201xM) were significantly lower (P<0.001). Saturated FFA
were higher in V (41%) and A (44%) than inM (30%) and (32%).
Monounsaturated FFA were predominant in M (43%) and lower in
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the same in (25%) andM (25%) and lower in V and A (16%). The
most striking differences concerned polyunsaturated FFA, which
were low in M (2.5%) and three-fold higher in I, A and V (10%,
P<0.001); consequently the concentration of C20:4 and C22:6 were
three-to-four-fold higher in intervillous space (40 and 161xM) than
in M (12 and 4txM) or in cord blood (13txM and 5txM). Immuno-
quantification of AFP showed a transplacental gradient. The AFP
concentrations is high in V and A and also, surprisingly, in the
intervillous blood. Very low concentration ofAFP were detected in
M. Thus the presence of the fetal protein which strongly bindPUFA
is correlated with the high percentage of this class of FFA. Hence,
a special AFP conformation (less immunoreactive and more an-
ionic) is evidenced in the intervillous space, suggesting that AFP is
heavily loaded with PUFA at the fetal-maternal interface. These
results suggest that the fetal-maternal interface, with its high levels
of AFP and PUFA, could play a key role in the maternal-fetal
immune interaction; these factors would enable the fetal allograft to
survive or trigger parturition.
Investigation of Chlamydia trachomatis Specific Antibodies in
Mothers with Stillbirth. Gencay M, Koskiniemi M, Puolakkainen
M, Ammala P, Wahlstrom T, Vaheri A, Narvanen A. Haartman
Institute, Department of Virology and Pathology (M.G., M.K.,
M.P., T.W., A.V.); University Central Hospital, Obstetrics and Gy-
necology (P.A.); University of Helsinki and Labsystems Research
(A.N.), Helsinki, Finland.
Objective: Stillbirth often remains without identified cause. The
aim of this study was to find out the association between stillbirth
and maternal serological status.
Methods: A total of 90 consecutive mothers with stillbirth between
July 1994 and March 1997 were prospectively studied. Serum
samples of 77 mothers were studied for C. trachomatis antibody
using a peptide based enzyme immunoassay (EIA), and 73 of them
with both EIA and Western blotting. In the peptide based EIA, 12
amino acids long synthetic peptides from the VP4 region of C.
trachomatis MOMP were used as antigen in solid phase indirect
EIA. The serum samples were also tested for human parvovirus
B 19, HSV-1, HSV2, VZV, cytomegalovirus and Toxoplasma gon-
dii antibody using EIA, and for C. pneumoniae antibody using a
microimmunofluorescence test. Maternal medical history was ob-
tained by interview and from hospital records. The fetuses were
autopsied.
Results: We found IgG antibodies to C. trachomatis in 49% of
mothers with stillbirth compared to 23% in fertile age controls
(P<0.01). IgG antibodies were detected in 47% and IgA in 25% of
cases compared to 21% in controls (P<0.01 and P<0.05) respec-
tively. Sensitivity of the peptide EIA test was 90% and specificity
77% when reactivity with C. trachomatis MOMP in immunoblot
was used as a reference. The C. trachomatis seropositive stillbirth
group presented more often with maternal history of C. trachomatis
infection than the seronegative stillbirth group (13% vs. 5%). Se-
roprevalence of other antibodies was similar in the two groups,
except IgG antibodies to T. gondii which were more frequent in the
C. trachomatis seropositive mothers than in the seronegatives
(P<O.05).
Conclusion: C. trachomatis seropositivity was significantly asso-
ciated with stillbirth. Maternal history of laboratory-confirmed
genital C. trachomatis infection and seropositivity suggest chronic
chlamydial infection as an associated agent in stillbirth.
CMV Serologic Status of Health Workers. V6ron M, Antog-
narelli F, Huraux JM, Fillet AM, Wargon C. Hospital Piti6-
Salpetribre, Dept. of Occupational Medicine, Paris, France.
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Objective: To evaluate cytomegalovirus (CMV) risk of female
employees working in health care services (pediatrics unit, nurser-
ies, infectious diseases, kidney transplant unit).
Methods: A retrospective analysis of CMV serologic status of
women working in exposed services compared to a control group in
non-exposed services between 1993-1996 was undertaken at the
Department of Occupational Medicine, Hospital Piti6-Salpetrire,
Paris, France.. The CMV serologic status was performed at first
examination during recruitment or after blood exposure of the
agents. 373 women, aged 18-52 years, including nurses, nursing
auxiliary staff and physicians were examined.
Intervention: To calculate the number of seronegative cases and
the seroconversion rate per age classes.
Main Outcome Measures: To determine whether or not the con-
tamination was professional or extra-professional. To define the
best strategies for primary prevention in women working in ex-
posed services.
Results and Conclusion: No seroconversion was observed in the
women’s cohort. One seroconversion was observed with a man.
The percentage of seronegative women aged 18-32 years was
58.5% and 29.3% for women aged 33-52 years. These results em-
phasize the need for an effective program of primary prevention.
Three Cases of Second-Trimester Abortion due to B Strepto-
coccus. Henry-Suchet J, Lokiec-Zerah MH. CHJ. Rostand Sevres
(J.H.-C.); Laboratoire Lokiec-Zerah 11 Rue De Cambronne 15e
(M.H.L.-Z.).
Invasive B streptococcal infection affects an estimated 3 per 1000
live births. Prenatal morbidity and maternal pathology due to this
infection are substantial, but this microorganism is not considered
as a cause of late abortion to date. However, some cases have been
previously reported by Christensen et al. and Daugaard et al. We
report 3 cases of second-trimester infectious abortion, with positive
cultures for B streptococcus alone in fetus samples, placenta and
amniotic fluid. Of the 3 women, 2 had cervical incompetence and
a past history of legal abortions. None of them had urinary in-
fection. In one case, the infection was recurrent, the patient having
had 2 previous late abortions with maternofoetal septicemia due to
B streptococcus. She achieved a further full term pregnancy after
being treated with Augmentin(R) (amoxicillin-clavulanic acid) dur-
ing the second trimester of pregnancy. These cases suggest that
prevention strategy such as prenatal vaginal screening, maternal
immunization or local/general antibiotherapy for B streptococcus
carriers should be organized in pregnant women having or suscep-
tible to have a pathological cervix.
1.Christensen et al. (1982)
2.Daugaard et al. (1988).
Ectopic Pregnancy and Chlamydial Hsp60 Serology--
Correlation Between Histopathology, Adhesions and Serologic
Responses to 13 Major Epitopes. Sziller I, Witkin SS, Ziegert M,
Csapo Z, Ujhazy A, Papp Z. Department of Obstetrics and Gyne-
cology, Semmelweis University Medical School, Budapest, Hun-
gary; Division of Immunology and Infectious Diseases, Department
of Obstetrics and Gynecology, The New York Hospital-Cornell
Medical Center, New York, NY.
Objectives: To evaluate clinical correlations of immunoreactivity
to epitopes of the chlamydial 60 kDa heat shock protein (hsp60)
among patients with ectopic pregnancy.
204 INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGYABSTRACTS
Method: In a case-control study, serologic responses to 13 syn-
thetic peptides corresponding to major epitopes of the chlamydial
hsp60 were tested in 67 patients treated for ectopic pregnancy.
Results: Among patients with ectopic pregnancy, anti-chlamydial
serology correlated with histologic evidence of chronic salpingitis
(p 0.02), pelvic adhesions (p 0.01), and previous treatment for
pelvic inflammatory disease (PID) (p 0.02). Seropositive patients
with ectopic pregnancy were more likely than seronegative patients
with ectopic gestation to have antibodies to synthetic peptides (p
0.0001). Plasma cell salpingitis was detected in 29 (43.3%) of the
ectopic patients. Its presence correlated with antibodies to two
hsp60 epitopes, encompassing amino acids 260-271 and 411-422
(p 0.02). Antibodies to these two epitopes, along with 5 other
epitopes, also correlated with peritubal adhesion formation in ec-
topic patients (p 0.01). Antibodies to epitopes 260-271 and 188-199
also correlated with a history of PID (p 0.05). Patients positive
for both C. trachomatis and hsp60 epitope antibodies had an in-
creased prevalence over controls in their prevalence of salpingitis,
pelvic adhesions or history of PID. In contrast, patients who were
positive for only C. trachomatis antibodies or only hsp60 epitope
antibodies did not differ from antibody-negative patients in each of
these correlates.
Conclusions: Immunoreactivity to specific epitopes within the
chlamydial hsp60 correlated with pelvic adhesions, histologic
plasma cell salpingitis and a history of PID among women with
ectopic pregnancy who were positive for antibodies to C. tracho-
matis. This observation strongly suggests that a C. trachomatis
infection may be necessary for the induction of hsp60-related tubal
immunopathology.
Cyclic Nucleotide Phosphodiesterases in Human Myometrium:
Potential Targets for Relaxant and Anti-Inflammatory Agents.
Leroy MJ, Mehats C, Tanguy G, Robert B, Dallot E, Mignot TM,
Duc-Goiran P, Ferrb F. Inserm U361, Pavillon Baudelocque, Uni-
versit6 Rent Descartes, Paris, France.
During human pregnancy, the uterus undergoes considerable struc-
tural and functional changes characterized by relaxation along with
hypertrophy and hyperplasia of the smooth muscle fibers of the
uterine wall. Although the contribution of cyclic nucleotides
(cAMP and cGMP) to uterine growth has not been completely
determined, increasing evidence suggests that these second mes-
sengers play an important role in myometrial relaxation. The phos-
phodiesterase enzymatic system (PDE) catalyzes and regulates the
hydrolysis of cAMP and cGMP and thereby constitutes a critical
factor in the control of intracellular concentrations of these mes-
sengers. Based on gene families encoding for PDE activity, the
superfamily can be divided into at least seven subtypes. Multiple
related genes and different mRNA splice forms create various iso-
forms which are differentially expressed and regulated in individual
cell types. From a pharmacological perspective, this complexity
implies that individual PDEs are likely good targets for therapeutic
intervention in diseases caused or regulated by cyclic nucleotide
modulated transduction mechanisms. Cyclic nucleotide PDEs were
examined in extracts of human myometrium. Based on the poten-
cies of selective PDE inhibitors, five different PDE families (PDE
to 5) have been characterized in the cytosolic fraction of pregnant
and non-pregnant tissues. Among them the cAMP-specific PDE
family (PDE4) was shown to be the most predominant.1 Rolipram,
which is a selective inhibitor of the PDE 4 family, was also a potent
in vitro inhibitor of spontaneous contractions in near term myome-
trium. To date, four distinct PDE genes (1A, 1B, 1C and 1D)
have been identified. Using semi-quantitative RT-PCR, we ana-
lyzed the expression pattern of myometrial PDE 4 transcripts in
myometrium of pregnant and non-pregnant women. Concurrent ex-
pression of PDE 4A, 4B, 4C and 4D mRNAs has been demon-
strated. Interestingly, the transcript of PDE 4B is more abundant in
myometrium of pregnant than of non-pregnant women, while no
difference between both tissues was detected for PDE 4A, 4C and
4D mRNAs. Determining whether the level of expression of PDE
4B mRNA subtype may be directly influenced by steroid hormone
modification is under investigation. The physiological implications
of these different molecular forms of PDE 4 in the maintenance of
pregnancy as well as in the onset of parturition is of particular
clinical interest. There are many etiologies for premature birth, but
research in this area increasingly points to infectious diseases. A
generation of more selective PDE 4 inhibitors with relaxant and
anti-inflammatory properties has recently been developed. We can
expect that such new drug strategies will be the basis of attempts to
improve the treatment of prematurity which still constitutes the
major cause of neonatal morbidity and mortality in humans.
1.(Leroy et al, Cell. Signal, 1994, 6, 405).
2.(Leroy et al, Biochem Pharmacol. 1989, 38, 9).
Expression of Endogenous Retrovirus (ERV-3) mRNA is Coin-
cident with Intercellular Fusion in a Choriocarcinoma Model of
Trophoblast Differentiation. Lin L, Xu B, Rote NS. Departments
of Microbiology and Immunology and Obstetrics and Gynecology,
Wright State University School of Medicine, Dayton, OH, USA.
ERV-3 is a human endogenous retroviral genome with an open
reading frame in the env gene that is expressed in placental syncy-
tiotrophoblast and during in vitro trophoblast differentiation, sug-
gesting a role in that process. The choriocarcinoma cell line BeWo
is a trophoblast model that is undifferentiated and can be induced to
undergo differentiation by the addition of forskolin. A 3.5kb ERV-3
env-specific mRNA is expressed in forskolin-treated cells concur-
rently with the production of human chorionic gonadotropin (b-
hCG) mRNA. In this study, we evaluated the relationship between
differentiation-related expression of ERV-3 env-specific mRNA
and intercellular fusion. Cell fusion was determined by immuno-
fluorescent staining for the loss of intercellular membranes by an-
tibodies against E-cadherin; by 48 hours with forskolin, 80% of
cells were fused to form syncytia. A digoxigenin-labeled ERV-3
cRNA probe was used in in situ hybridization to study the local-
ization of ERV-3 mRNA in BeWo cells undergoing fusion. ERV-3
mRNA was expressed in all cells undergoing intercellular fusion
and was not expressed in undifferentiated BeWo cells. Expression
of ERV-3 mRNA increased progressively and in parallel with in-
creasing syncytium formation and was maximum at 72 hours. In
situ hybridization controls included sense and antisense probes and
treatment of BeWo cells with RNase. The localization of ERV-3
env-specific mRNA is related to intercellular fusion, suggesting
that ERV-3 could play a role in that process. To study further this
relationship, we established BeWo sublines containing a plasmid
with either sense or anti-sense ERV-3 env-specific mRNA. The
effects of overproduction of ERV-3 env-specific mRNA are cur-
rently under investigation.
Maternal Serum Early Pregnancy Factor in Multiple Pregnan-
cies. Zheng Zhen-Qun, Fan Xiao-Guang, Ma Ai-Ying, Qiao Chang-
Xin. ShanXi Medical University, Talyuan 030001 PR China.
Early pregnancy factor (EPF), a pregnancy associated immunosup-
pressive molecule, was detected in the pregnant serum of a mouse
within 6 hours of mating, and its activity was also detected in the
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Period of Twin Singleton
pregnancy pregnancy pregnancy
First trimester 8.5 (n 2) 6.7 (n 15)
Second trimester 7.3 (n 4) 5.4 (n + 15)
Third trimester 5.0 (n 16) 4.4 (n 15)
Third trimester triple pregnancy EPF; 7.0 (n I).
human maternal serum at a very early stage after fertilization. To
investigate the normal distribution of EPF in the human body, we
have found its activity in pregnant maternal serum, cervical mucus,
amniotic fluid and fetal serum. In the present study, we have de-
tected EPF activity in multiple pregnancy maternal serum by rosette
inhibition assay (Table 1). EPF activity is measured by its capacity
to enhance the ability of anti-lymphocyte antibody (CD3) to inhibit
active spontaneous rosette formation between lymphocytes and
sheep red blood cells. EPF activity was expressed as rosette inhi-
bition titer (RIT). The results of this study showed that EPF activity
in multiple pregnancy is higher than in singleton pregnancy. It is
confirmed again that EPF is produced by fetal tissues.
Immunological Aspects of Viral Infections in Pregnancy.
Zaidieva ZS, Dantchenko OV, Tioutiohnnik VL, Ignatchenko AA,
Krochinina NL. Research Centre of Obstetrics, Gynecology and
Perinatology, Moscow, Russia.
The need to study genital herpes virus (HSV) and cytomegalovirus
(CMV) is mandated by a continuing increase of the number of
patients affected by these disorders, the high rate of perinatal losses
and the birth of babies with severe brain damage. We have studied
182 pregnant women with HSV and CMV; 167 patients had initial
manifestation of infection in the course of pregnancy. Herpes in-
fection which occurred after the 32nd week of pregnancy has af-
fected 20% of the newborns, while infection occurring shortly be-
fore labor has infected 40% of the newborns. All patients have been
diagnosed using immunological methods. Analysis of the subpopu-
lations of peripheral blood lymphocytes in pregnant women with
genital herpes revealed a reduction in the levels of T-lymphocytes
(CD3+), an increase in the levels of T-suppressor cells (CD8+) and
B-cells (CD19+) and a significant reduction in the level ofT-helper
cells (CD4+). No significant deviations from normal levels of these
cells were detected in women with reactivation of CMV infection.
The choice of treatment methods and optimum ways of delivery are
currently of the major interest. We have developed a unique method
of immunoglobulinotherapy. We have used this method to treat 170
patients with a history of pregnancy loss caused by generalized
infection, persistent spontaneous abortions and non-developing
pregnancy. In particular, we have prescribed intravenous injections
of immunoglobulin (3 gm every other day for 7 days). The com-
parison of the state of the immune system prior to the treatment and
after has manifested the tendency to increase the number of T-
lymphocytes caused by the increase of the number of T helpers.
Immunological Studies and Treatment of Women with Unex-
plained Recurrent Spontaneous Abortions. Georgieva R,
Belchev D, Kinkina S, Minev M. Institute of Biology and Immu-
nology of Reproduction (R.G.); Regional Hospital "Dr. R. An-
gelov" (D.B., S. K.); "Pirogov" Emergency Medical Institute
(M.M.), Sofia, Bulgaria.
ABSTRACTS
Recurrent spontaneous abortions (RSA) are a complicated, multi-
factorial and unsolved problem. An immunologic etiology for this
form of abortion has been proposed. In this study, after screening of
infertile couples with RSA, 65 couples were classified in the first
group: those couples in which a woman had no child born by her
partner, the abortions occurred prior to the 20th week of gestation
and the women had no lymphocytotoxic antibodies in their serum.
The average age of these couples was 26.2 years for women and
31.0 for the men. In the second group were 35 women who had at
least one pregnancy that resulted in a live birth or stillbirth after 20
weeks of gestation and antipaternal lymphocytotoxic antibodies in
the serum. The mean age of this group was 28.5 years for the
women and 32.5 for the men. The number of consecutive abortions
in both groups varied from 2 to 6. Fertile couples with 2 or more
normal deliveries as well as conventionally treated patients were
used as controls. The lymphocyte subsets and the kinetics of anti-
paternal lymphocytotoxic antibodies were followed during the
therapy. The couples were HLA typed for A, B, C and DR antigens.
The treatment of the first group consisted of leukocyte immuniza-
tion including intravenous application of 3X108-3X109 husband’
or donor’s WBC (in volume of 50-200 ml) 1-2 times prior to
conception and intravenous infusions 2 to 4 times during pregnancy
in 4-6-week intervals. The women in the second group were treated
with low doses of heparin, 2500 U to 5000 U s.c. twice daily at
12-hour intervals, from the beginning of pregnancy up to 34th or
35th week of gestation. Successful pregnancy was obtained in
81.5% of the immunized women and 75% of the heparin-treated
women. All babies are normal and alive up to today. Maternal-
paternal HLA-antigen sharing at 2 loci was found to be signifi-
cantly different from that in normal pregnancy. After immuniza-
tion, the sera from 28% of women were seroconverted to antipa-
ternal lymphocytotoxic antibodies. The CD8+ lymphocytes were
decreased in women with RSA and CD4+/CD8+ ratio increased. A
slight reduction in the content of CDllb+ and IILA-DR+ cells,
expressing activation markers was found in some patients. There
were no significant changes depending on the therapy.
Blockage of Implantation in the Rat by a Monoclonal Antibody
(MAG). Nemeth G, Kliman HJ, Naftolin F. Department of Obstet-
rics and Gynecology, Albert Szent-Gyorgyi Medical University,
Szeged, Hungary (G.N.); Department of Obstetrics and Gynecol-
ogy, Yale University, School of Medicine, New Haven, CT, USA
(H.J.K., F.N.).
Introduction: Implantation is the process by which the blastocyst
becomes intimately attached to the endometrium. Synchronization
between embryonic and uterine development ("implantation win-
dow" or "receptive phase") is necessary for successful implanta-
tion in the rodent and human. Recently our group discovered that
normal cycling endometrial glands contain an epitope found in the
Golgi apparatus of the cell that is strongly reactive with IgG anti-
bodies in numerous murine ascites. Since MAG (mouse ascites
Golgi) appears on the endometrial surface at the time of the "im-
plantation window," we speculated that it may play a critical role
in the initial adherence of the blastocyst to the endometrium at the
time of implantation.
Methods: Mature female rats were kept on the cycle of 14:10 hour
light:dark. Vaginal smears were taken daily between 9:30 and 10
am. No animal was used for an experiment until at least two con-
secutive four-day cycles had been observed. The anti-implantation
effect ofMAG was tested by the intraperitoneal injection of 0.4 ml
of anti-MAG antibody or anti-MAG-negative ascites fluid admin-
istered in late diestrus. The animals were mated on the next day,
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and on day 15 the animals were sacrificed and the number of
implantations was counted.
Results: The anti-implantation effect ofMAG was almost complete
when the anti-MAG was injected in late diestrus, before ovulation
and coitus. (1.8+1.2, n=5 vs. 16.8+/-0.37, n=5, P <0.01). The
weight per implantation site was almost the same comparing treated
and control groups, indicating that the pregnancies proceeded nor-
mally if they implanted.
Conclusions: Our findings suppose a significant role of MAG in
the implantation process, but more studies are needed to elucidate
the mechanism of MAG action.
The Immunology of a Fetus with the Chronic Pyelonephritis of
Pregnant Women. Bystritskaya TS, Melachova TA, Kozayeva TZ.
Blagoveshchensk, Russia.
The aim of the work is to determine the immunologic criteria of the
intrauterine fetus being infected by pregnant women with the
chronic pyelonephritis. 100 pregnant women with chronic pyelo-
nephritis in the third term and their infants (basic groups), 10
healthy women and their infants (control groups) were examined.
The quantity of CD3+, CD4+, CD8+, CD72+lymphocytes and im-
munoglobulins IgA, IgM, IgG in the serum of blood of the pregnant
women and from the umbilical cord (arteries and veins were sepa-
rated) was studied with the help of the method of direct and indirect
fluorescence. Under the latent course of pyelonephritis of the preg-
nant women, the quantity of CD3/, CD4 CD8+lymphocytes was
considerably smaller than in the control group. In the arterial and
venous blood from the umbilical cord, the decrease of CD3-
lymphocytes happened mainly because of CD8- lymphocytes and
CD72+lymphocytes. IgM and IgG were higher than in the control
group. The arterio-venous difference was revealed. The decrease of
CD3+, CD4+, CD8 lymphocytes of the pregnant women with the
recurrent pyelonephritis was more expressed than with the latent
ones or in the control group. In the blood of the infants of these
women, the decrease of CD3+, CD8 and the increase of CD72
lymphocytes is more significant both in the artery and in the vein.
The arteries venous difference is not significant. With the presence
of clinical signs of infection of a fetus, the depression of T- and
B-system of immunity was established.
Non-Specific Immunoprophylaxis of the Intrauterine In-
fection in Pregnant Women With Chronic Pyelonephritis.
Melachova TA, Bystritskaya TS, Sudakov AA. Blagoveshchensk,
Russia.
Non-specific immunoprophylaxis of the intrauterine infection (IUI)
by means of essential forte was carried out in 30 pregnant women
with chronic pyelonephritis in the critical periods of the formation
and development of the fetus immune system (the main group). The
immunoprophylaxis consisted of 5 courses of treatment. 20 preg-
nant women in the control group did not take essential forte. The
efficiency of the treatment was assessed by the clinical data, the
amount of CD3+, CD4+, CD8+, CD16, and CD72+lymphocytes,
immunoglobulins IgA, IgM, and IgG and placental proteins
PAMG-1 and AMGF in the blood of the pregnant women and
infants. The increase of the absolute amount of CD3/, CD4+,
CD8+lymphocytes and the decrease of the absolute amount of
CD72+lymphocytes and the placental proteins were revealed in the
course of treatment in the main group. In the blood of the infants of
these mothers we revealed considerable differences in the amount
of immunocompetent cells and the placental proteins in comparison
with the infants of the control group. The number of the infants with
IUI in the main group was 1.5 times less than in the control group.
The Immunological Criteria of Preclinical Forms of Gestoses in
Adolescents Primiparous. Kozayeva TZ, Bystritskaya TS, Pozhv-
dayev VV. Blagoveshchensk, Russia.
The purpose of this investigation is to study the state of cellular and
humoral factors of immunity in adolescents primiparous (AP) with
the gestosis for early diagnostics and prophylaxis. 40 AP were
examined during their pregnancies. In 30, a gestosis of an easy form
developed (the basic group). In 10, pregnancy was taking its normal
course (the control group). For the determination of CD3, CD4,
CDS, CD72 lymphocytes in the serum of blood, the reaction of
direct and indirect immunofluorescence with monoclonal antibod-
ies was used. The content of immunoglobulin (Ig) in the blood was
studied by the method of radial diffusion in gel (method of
Manchini). In AP in the first term of pregnancy, the absolute quan-
tity of CD3, CD4, and CD72+lymphocytes was higher than in the
pregnant women of reproductive age of the Far-Eastern region.
The increase of the quantity of CD3+lymphocytes in AP was due to
CDS+lymphocytes. The content of Ig A, IgM and IgG was not
considerably different. In the AP of the basic group during the 21 st
week of pregnancy, the absolute quantity of CD3 lymphocytes
increased in comparison with the quantity of these cells in the
control group (P 0.05). The content of IgG and IgM increases two
times. It is the diagnostic test of the preclinical forms of gestosis. In
the third term of pregnancy in AP, the absolute quantity of
CD3+lymphocytes did not truly differ from their quantity in the first
term, but the change of ratio ofCD4 and CDS+lymphocytes due to
the decrease of CD8 was revealed. The content of IgG increased
two times. With the appearance of clinical signs of gestosis,
changes in T-and B-systems of immunity are more expressed.
1.(T.S. Bystritskaya 1993).
INFECTIOUS DISEASES IN OBSTETRICSAND GYNECOLOGY 207